Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
128 studies found for:    Open Studies | "Lupus Erythematosus, Systemic"
Show Display Options
Rank Status Study
21 Not yet recruiting Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Belimumab
22 Not yet recruiting A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Placebo;   Drug: M2951
23 Recruiting Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus
Condition: Systemic Lupus Erythematosus
Intervention: Other: therapeutic education
24 Recruiting Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
25 Recruiting A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: hrIL-2 active;   Drug: hrIL-2 placebo
26 Recruiting A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: RSLV-132;   Drug: Placebo
27 Recruiting Study of IFN-K in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Biological: IFN-Kinoid;   Other: Placebo;   Other: ISA 51
28 Recruiting A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Biological: XmAb5871;   Biological: Placebo to match XmAb5871
29 Recruiting Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Tofacitinib;   Drug: Placebo
30 Recruiting Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous
Condition: Systemic Lupus Erythematous
Intervention: Drug: Treatment by clopidogrel
31 Recruiting A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Baricitinib;   Drug: Placebo
32 Recruiting Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BT063;   Biological: Placebo
33 Not yet recruiting ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: ILT-101;   Drug: Placebo
34 Not yet recruiting A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: GDC-0853 (high dose);   Drug: GDC-0853 (low dose);   Drug: Placebo
35 Recruiting Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Placebo plus standard therapy;   Biological: RC18 80 mg plus standard therapy;   Biological: RC18 160 mg plus standard therapy;   Biological: RC18 240 mg plus standard therapy
36 Recruiting Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus;   SLE
Interventions: Drug: Mycophenolate Mofetil;   Drug: Hydroxychloroquine or Chloroquine;   Drug: Prednisone
37 Recruiting Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Other: Drug free;   Drug: HCQ;   Drug: GC+HCQ
38 Recruiting Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus (SLE)
Intervention:
39 Recruiting CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Blisibimod;   Drug: Placebo
40 Recruiting Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.